Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Entospletinib effectively prevents eye and skin GVHD in mice.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Candida antigen is an effective and promising treatment for alopecia areata.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Promising cancer treatments were found, but the manufacturer closed.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Topical oligonucleotide therapy targets hair follicles effectively.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Emulgels effectively deliver hydrophobic drugs for skin conditions like acne and psoriasis.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Nanotechnology can effectively deliver antimicrobial peptides for treating infections.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.